Our difference is our platform
INTAC® is created via hot melt extrusion (HME) and is adaptable to immediate (IR) and extended (ER) release products. Its flexibility also allows for different modified (MR/XR) release formulations.
Process overview of INTAC® hot-melt extrusion manufacturing of IR or ER release ADF dosage forms
ER: The HME process creates a long extrudate strand, which is then cut and shaped to form ER products.
IR: Instead of one long strand, the HME process creates pellets that can be further processed into IR tablets or capsules.
MR/XR: Combinations of approaches can provide access to a wide range of modified release products with specific profiles of API release.